M Buerke Selected Research

M Buerke Research Topics

Disease

11	Cardiogenic Shock 01/2021 - 09/2004
9	Myocardial Infarction 01/2021 - 01/2000
6	Inflammation (Inflammations) 01/2018 - 02/2001
4	Heart Failure 01/2021 - 01/2001
4	Hemorrhage 01/2018 - 02/2007
4	Reperfusion Injury 09/2008 - 06/2000
3	Infections 05/2016 - 12/2003
3	Endocarditis 05/2016 - 02/2012
3	Multiple Organ Failure (MODS) 06/2014 - 11/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 08/2011 - 06/2000
3	Sepsis (Septicemia) 03/2011 - 01/2000
3	Septic Shock (Toxic Shock Syndrome) 03/2005 - 01/2000
2	Shock 01/2018 - 04/2008
2	Infarction (Infarctions) 01/2018 - 08/2011
2	Body Weight (Weight, Body) 10/2015 - 11/2001
2	Thrombosis (Thrombus) 09/2011 - 07/2002
2	Thrombocytopenia (Thrombopenia) 04/2011 - 02/2007
2	Ischemia 03/2011 - 02/2000
2	Necrosis 09/2008 - 11/2001
2	Neointima 02/2003 - 02/2000
2	Asthma (Bronchial Asthma) 06/2001 - 02/2001
2	Pneumonia (Pneumonitis) 06/2001 - 02/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Critical Illness (Critically Ill) 05/2017
1	Thromboembolism 03/2017
1	Pulmonary Arterial Hypertension 12/2014
1	Renal Insufficiency (Renal Failure) 02/2013
1	Hypertension (High Blood Pressure) 02/2013
1	Peripheral Arterial Disease 02/2013
1	Coronary Disease (Coronary Heart Disease) 02/2013
1	Anemia 02/2013
1	Stroke (Strokes) 02/2013
1	Heart Diseases (Heart Disease) 10/2010
1	Tachycardia (Tachyarrhythmias) 07/2008
1	Hypotension (Low Blood Pressure) 07/2008
1	Non-ST Elevated Myocardial Infarction 02/2007
1	Acute Kidney Injury (Acute Renal Failure) 03/2005
1	Acidosis 09/2004

Drug/Important Bio-Agent (IBA)

3	Dobutamine FDA LinkGeneric 01/2018 - 06/2015
3	Simendan (Levosimendan)IBA 02/2017 - 03/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2016 - 03/2005
3	CytokinesIBA 09/2012 - 06/2001
3	Heparin (Liquaemin)FDA LinkGeneric 04/2011 - 01/2000
2	AnticoagulantsIBA 01/2018 - 10/2015
2	CatecholaminesIBA 06/2015 - 09/2004
2	CreatinineIBA 02/2013 - 03/2005
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2013 - 01/2000
2	Clopidogrel (Plavix)FDA Link 09/2011 - 07/2002
2	CalciumIBA 03/2011 - 06/2000
2	Proteins (Proteins, Gene)FDA Link 09/2008 - 02/2003
2	cariporideIBA 04/2008 - 06/2000
2	Thrombin FDA Link 04/2008 - 01/2000
2	Glycoproteins (Glycoprotein)IBA 02/2007 - 01/2000
2	Oxygen (Dioxygen)IBA 09/2004 - 11/2001
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2002 - 01/2000
2	OvalbuminIBA 06/2001 - 02/2001
2	DNA (Deoxyribonucleic Acid)IBA 06/2001 - 02/2001
2	Antisense OligonucleotidesIBA 06/2001 - 02/2001
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2001 - 02/2000
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018
1	N(4)-oleylcytosine arabinosideIBA 03/2017
1	Vitamin K FDA Link 10/2015
1	Prothrombin (Factor II)IBA 10/2015
1	prothrombin complex concentrates (PPSB)IBA 10/2015
1	C-Reactive ProteinIBA 06/2014
1	oxidized low density lipoproteinIBA 02/2013
1	LDL CholesterolIBA 02/2013
1	Hemoglobins (Hemoglobin)IBA 02/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2012
1	TroponinIBA 08/2011
1	argatroban (MPQA)FDA Link 04/2011
1	Bacterial ToxinsIBA 03/2011
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 11/2008
1	Creatine Kinase (Creatine Phosphokinase)IBA 09/2008
1	Aprotinin (Trasylol)FDA Link 09/2008
1	Tenecteplase FDA Link 07/2008
1	HydrogenIBA 04/2008
1	SodiumIBA 04/2008
1	P-SelectinIBA 04/2008
1	Platelet Membrane Glycoprotein IIbIBA 02/2007
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 03/2005
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 03/2005
1	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2005
1	fibrin fragment D (D-dimer)IBA 03/2005
1	Erythromycin (Erycette)FDA LinkGeneric 03/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2005
1	Immunoglobulins (Immunoglobulin)IBA 03/2005
1	ProcalcitoninIBA 03/2005
1	Protein CIBA 03/2005
1	Sympathomimetics (Sympathomimetic Amines)IBA 09/2004

Therapy/Procedure

22	Therapeutics 02/2019 - 01/2000
4	Critical Care (Surgical Intensive Care) 01/2021 - 03/2004
3	Percutaneous Coronary Intervention 01/2018 - 02/2007
3	Stents 01/2018 - 09/2011
2	Drug Therapy (Chemotherapy) 01/2018 - 11/2008
2	Intranasal Administration 06/2001 - 02/2001
1	Length of Stay 11/2015
1	Emergency Treatment 01/2013
1	Thrombolytic Therapy 07/2008
1	Duration of Therapy 09/2004